Vol 14, No 2 (2018)
Guidelines / Expert consensus
Published online: 2018-04-26
Cancer in pregnant women
DOI: 10.5603/OCP.2018 .0011
Oncol Clin Pract 2018;14(2):62-78.
Abstract
Not available
References
- Peccatori FA, Azim HA, Orecchia R, et al. ESMO Guidelines Working Group. Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013; 24 Suppl 6: vi160–vi170.
- Voulgaris E, Pentheroudakis G, Pavlidis N. Cancer and pregnancy: a comprehensive review. Surg Oncol. 2011; 20(4): e175–e185.
- Amant F, Deckers S, Van Calsteren K, et al. Breast cancer in pregnancy: recommendations of an international consensus meeting. Eur J Cancer. 2010; 46(18): 3158–3168.
- Amant F, Loibl S, Neven P, et al. Breast cancer in pregnancy. Lancet. 2012; 379(9815): 570–579.
- Loibl S, Han SN, Amant F. Being Pregnant and Diagnosed with Breast Cancer. Breast Care (Basel). 2012; 7(3): 204–209.
- Nowecki Z. i wsp. Standardy postępowania diagnostyczno-terapeutycznego u kobiet w ciąży chorych onkologicznie. Inwazyjny rak piersi u ciężarnych zgłoszone do druku 10.2016.
- Calsteren KV, Verbesselt R, Devlieger R, et al. Transplacental transfer of paclitaxel, docetaxel, carboplatin, and trastuzumab in a baboon model. Int J Gynecol Cancer. 2010; 20(9): 1456–1464.
- Van Calsteren K, Verbesselt R, Beijnen J, et al. Transplacental transfer of anthracyclines, vinblastine, and 4-hydroxy-cyclophosphamide in a baboon model. Gynecol Oncol. 2010; 119(3): 594–600.
- Cardonick E, Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol. 2004; 5(5): 283–291.
- Rogers JE, Dasari A, Eng C. The Treatment of Colorectal Cancer During Pregnancy: Cytotoxic Chemotherapy and Targeted Therapy Challenges. Oncologist. 2016; 21(5): 563–570.
- Pavlidis NA. Coexistence of Pregnancy and Malignancy. Oncologist. 2002; 7(4): 279–287.
- US Deprtm.of Health and Human Services. National Toxicology Program 2013 2013.
- Hahn KME, Johnson PH, Gordon N, et al. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer. 2006; 107(6): 1219–1226.
- Peccatori FA, Azim HA, Scarfone G, et al. Weekly epirubicin in the treatment of gestational breast cancer (GBC). Breast Cancer Res Treat. 2009; 115(3): 591–594.
- Zagouri F, Sergentanis TN, Chrysikos D, et al. Platinum derivatives during pregnancy in cervical cancer: a systematic review and meta-analysis. Obstet Gynecol. 2013; 121(2 Pt 1): 337–343.
- Krzakowski M. Zalecenia postępowania diagnostyczno-terapeutycznego w nowotworach złośliwych 2013. In: Rubach M. ed. Nowotwory u kobiet w ciąży. Tom I. Via Media, Gdańsk 2013.
- Azim HA, Pavlidis N, Peccatori FA. Treatment of the pregnant mother with cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part II: Hematological tumors. Cancer Treat Rev. 2010; 36(2): 110–121.
- Lambertini M, Peccatori FA, Azim HA. Targeted agents for cancer treatment during pregnancy. Cancer Treat Rev. 2015; 41(4): 301–309.
- Pye SM, Cortes J, Ault P, et al. The effects of imatinib on pregnancy outcome. Blood. 2008; 111(12): 5505–5508.
- Mazonakis M, Tzedakis A, Varveris C, et al. Radiotherapy for supradiaphragmatic Hodgkin's disease: determination of the proper fetal shielding conditions using Monte Carlo methodology. Phys Med. 2011; 27(4): 181–187.
- Rizack T, Mega A, Legare R, et al. Management of hematological malignancies during pregnancy. Am J Hematol. 2009; 84(12): 830–841.
- Bakkal BH, Sayin M. Radiotherapy and Pregnancy: Together or Alone. Derleme Review. 2012; 19(2): 120–127.
- Kourinou KM, Mazonakis M, Lyraraki E, et al. Photon-beam radiotherapy in pregnant patients: can the fetal dose be limited to 10 cGy or less? Phys Med. 2015; 31(1): 85–91.
- Nuyttens JJ, Prado KL, Jenrette JM, et al. Fetal dose during radiotherapy: clinical implementation and review of the literature. Cancer Radiother. 2002; 6(6): 352–357.
- Osei EK, Faulkner K. Radiation risks from exposure to diagnostic X-rays during pregnancy. Radiography. 2000; 6(2): 131–144.
- Poortman P, Kaidar-Person O, Masset H, Lampka E. Radiotherapy during pregnancy. Textbook of Cancer in Pregnancy 2017: 17–24.
- Skrzypczyk-Ostaszewicz A, Jagielska B, Śpiewankiewicz B, et al. Rak piersi współistniejący z ciążą. Curr Gynecol Oncol. 2014; 12(1): 14–24.
- Loibl S, Schmidt A, Gentilini O, et al. Breast Cancer Diagnosed During Pregnancy: Adapting Recent Advances in Breast Cancer Care for Pregnant Patients. JAMA Oncol. 2015; 1(8): 1145–1153.
- Loibl S. Adjuvant therapy in patients with breast cancer during pregnancy. Cancer Treat Res. 2009; 151: 317–328.
- Toesca A, Gentilini O, Peccatori F, et al. Locoregional treatment of breast cancer during pregnancy. Gynecol Surg. 2014; 11(4): 279–284.
- Vrancken Peeters MJ, et al. Breast cancer during and after pregnancy. Eur J Cancer. 2010; 8: 31–32.
- Pieńkowski T, Skrzypczyk A. Ciąża i rak piersi. In: Dłużniewski M. ed. Ciąża - problemy internisty i kardiologa. Czelej 2012: 297–303.
- Amant F F, von Minckwitz G, Han SN, et al. Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study. J Clin Oncol. 2013; 31(20): 2532–2539.
- Al-Halal H, Kezouh A, Abenhaim HA. Incidence and obstetrical outcomes of cervical intraepithelial neoplasia and cervical cancer in pregnancy: a population-based study on 8.8 million births. Arch Gynecol Obstet. 2013; 287(2): 245–250.
- Azim HA, Botteri E, Renne G, et al. The biological features and prognosis of breast cancer diagnosed during pregnancy: a case-control study. Acta Oncol. 2012; 51(5): 653–661.
- Han SN, Mhallem Gziri M, Van Calsteren K, et al. Cervical cancer in pregnant women: treat, wait or interrupt? Assessment of current clinical guidelines, innovations and controversies. Ther Adv Med Oncol. 2013; 5(4): 211–219.
- Paraskevaidis E, Koliopoulos G, Kalantaridou S, et al. Management and evolution of cervical intraepithelial neoplasia during pregnancy and postpartum. Eur J Obstet Gynecol Reprod Biol. 2002; 104(1): 67–69.
- Amant F, Van Calsteren K, Halaska MJ, et al. Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study. Lancet Oncol. 2012; 13(3): 256–264.
- Evens A, Lishner M, Avivi I, Poortmans P, Lampka E. Hodgkin Lymphoma and Non –Hodgkin Lymphoma. Textbook of Cancer in Pregnancy 2017: 111–118.
- Germann N, Haie-Meder C, Morice P, et al. Management and clinical outcomes of pregnant patients with invasive cervical cancer. Ann Oncol. 2005; 16(3): 397–402.
- Amant F, Halaska MJ, Fumagalli M, et al. ESGO task force ‘Cancer in Pregnancy’. Gynecologic cancers in pregnancy: guidelines of a second international consensus meeting. Int J Gynecol Cancer. 2014; 24(3): 394–403.
- Giuntoli RL, Vang RS, Bristow RE. Evaluation and management of adnexal masses during pregnancy. Clin Obstet Gynecol. 2006; 49(3): 492–505.
- Machado F, Vegas C, Leon J, et al. Ovarian cancer during pregnancy: analysis of 15 cases. Gynecol Oncol. 2007; 105(2): 446–450.
- Patterson DM, Murugaesu N, Holden L, et al. A review of the close surveillance policy for stage I female germ cell tumors of the ovary and other sites. Int J Gynecol Cancer. 2008; 18(1): 43–50.
- Zhao XY, Huang HF, Lian LJ, et al. Ovarian cancer in pregnancy: a clinicopathologic analysis of 22 cases and review of the literature. Int J Gynecol Cancer. 2006; 16(1): 8–15.
- Ishioka Si, Hayashi T, Endo T, et al. Advanced epithelial ovarian carcinoma during pregnancy. Int J Clin Oncol. 2007; 12(5): 375–378.
- Behtash N, Karimi Zarchi M, Modares Gilani M, et al. Ovarian carcinoma associated with pregnancy: a clinicopathologic analysis of 23 cases and review of the literature. BMC Pregnancy Childbirth. 2008; 8: 3.
- El-Messidi A, Patenaude V, Abenhaim HA. Incidence and outcomes of women with non-Hodgkin's lymphoma in pregnancy: a population-based study on 7.9 million births. J Obstet Gynaecol Res. 2015; 41(4): 582–589.
- Froesch P, Belisario-Filho V, Zucca E. Hodgkin and non-Hodgkin lymphomas during pregnancy. Recent Results Cancer Res. 2008; 178: 111–121.
- Lishner M, Zemlickis D, Degendorfer P, et al. Maternal and foetal outcome following Hodgkin's disease in pregnancy. Br J Cancer. 1992; 65(1): 114–117.
- Sagan D, Semczuk A, Lampka E. Combination chemotherapy for Hodgkin's lymphoma during pregnancy: favorable outcome for mother and child. J Obstet Gynaecol Res. 2010; 36(4): 882–886.
- Bachanova V, Connors JM. Hodgkin lymphoma in pregnancy. Curr Hematol Malig Rep. 2013; 8(3): 211–217.
- Avilés A, Neri N, Nambo MJ. Hematological malignancies and pregnancy: treat or no treat during first trimester. Int J Cancer. 2012; 131(11): 2678–2683.
- Pereg D, Koren G, Lishner M. The treatment of Hodgkin's and non-Hodgkin's lymphoma in pregnancy. Haematologica. 2007; 92(9): 1230–1237.
- Pereg D, Koren G, Lishner M. Cancer in pregnancy: gaps, challenges and solutions. Cancer Treat Rev. 2008; 34(4): 302–312.
- El-Hemaidi I, Robinson SE. Management of haematological malignancy in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2012; 26(1): 149–160.
- Avivi I, Farbstein D, Brenner B, et al. Non-Hodgkin lymphomas in pregnancy: tackling therapeutic quandaries. Blood Rev. 2014; 28(5): 213–220.
- Vandenbriele C, Dierickx D, Amant F, et al. The treatment of hematologic malignancies in pregnancy. Facts Views Vis Obgyn. 2010; 2(2): 74–87.
- Rizack T, Mega A, Legare R, et al. Management of hematological malignancies during pregnancy. Am J Hematol. 2009; 84(12): 830–841.
- Roh M, Eliades P, Gupta S, et al. Cutaneous melanoma in women. Int J Womens Dermatol. 2015; 1(1): 21–25.
- Boussios S, Pentheroudakis G. Managing Cancer During Pregnancy. Springer 2016: 123–134.
- Kocian P, Lampka E, Stec R. Gastro-intestinal cancer. Textbook Cancer in Pregnancy 2017: 125–130.
- Sakamoto K, Kanda T, Ohashi M, et al. Management of patients with pregnancy-associated gastric cancer in Japan: a mini-review. Int J Clin Oncol. 2009; 14(5): 392–396.
- Boussios S, Han SN, Fruscio R, et al. Lung cancer in pregnancy: report of nine cases from an international collaborative study. Lung Cancer. 2013; 82(3): 499–505.
- Mitrou S, Petrakis D, Fotopoulos G, et al. Lung cancer during pregnancy: A narrative review. J Adv Res. 2016; 7(4): 571–574.
- Ali S, Jones GL, Culligan DJ, et al. British Committee for Standards in Haematology. Guidelines for the diagnosis and management of acute myeloid leukaemia in pregnancy. Br J Haematol. 2015; 170(4): 487–495.
- Chang A, Patel S. Treatment of acute myeloid leukemia during pregnancy. Ann Pharmacother. 2015; 49(1): 48–68.
- Kozakiewicz B. Nowotwory złośliwe u kobiet w ciąży. PZWL 2017: 111–113.
- Palani R, Milojkovic D, Apperley JF. Managing pregnancy in chronic myeloid leukaemia. Ann Hematol. 2015; 94 Suppl 2: S167–S176.
- Alimam S, Bewley S, Chappell LC, et al. Pregnancy outcomes in myeloproliferative neoplasms: UK prospective cohort study. Br J Haematol. 2016; 175(1): 31–36.
- Avivi I, Lishner M. Acute leukemia during pregnancy. Textbook of Cancer in Pregnancy : 105–109.
- Zaouri F, Maniou I. Managing Cancer During Pregnancy. Springer 2016: 89–95.
- Lambertini M, Skrzypczyk-Ostaszewicz A. Supportive therapy. Textbook Cancer in Pregnancy 2017: 39–45.